To accurately determine gene expression during other developmental phases, we suggest a similar approach as described in the present study. We thank Drs Hans Wolf-Watz and Betty Guo for critical reading of the manuscript. J.J. received fundings from the Wenner-Gren Foundation, Umeå

University, the Swedish Research Council (grant no. 621-2006-4450), and the European Union (BacRNA 2005 contract no. 018618); S.B. received funds from the Swedish Research Council (grant no. 07922). P.E. and L.B. contributed equally to this work. “
“Dengue disease is a mosquito-borne infection caused by Dengue virus. Infection may be asymptomatic or variably manifest as mild Dengue fever (DF) to the most Selleckchem Omipalisib severe form, Dengue haemorrhagic fever (DHF). Mechanisms that

influence disease severity are not understood. Complement, an integral SP600125 solubility dmso component of the immune system, is activated during Dengue infection and the degree of activation increases with disease severity. Activation of the complement alternative pathway is influenced by polymorphisms within activation (factor B rs12614/rs641153, C3 rs2230199) and regulatory [complement factor H (CFH) rs800292] proteins, collectively termed a complotype. Here, we tested the hypothesis that the complotype influences disease severity during secondary Dengue infection. In addition to the complotype, we also assessed two other disease-associated CFH polymorphisms (rs1061170, rs3753394) and a structural polymorphism within the CFH protein family. We did not detect any significant association between the examined polymorphisms and Dengue infection

severity in the Thai population. However, the minor allele frequencies of the factor B and C3 polymorphisms were less than 10%, so our study was not sufficiently Y-27632 2HCl powered to detect an association at these loci. We were also unable to detect a direct interaction between CFH and Dengue NS1 using both recombinant NS1 and DV2-infected culture supernatants. We conclude that the complotype does not influence secondary Dengue infection severity in the Thai population. “
“Whitehead Institute, Cambridge, MA, USA Maurus Curti, Viollier AG, Basel, Switzerland Autoimmune diseases develop when self-specific T cells that escaped negative selection initiate a harmful immune response against self. However, factors, which influence the initiation and progression of an autoimmune response remain incompletely understood. By establishing a double-transgenic BALB/c mouse system in which different amounts of a cell-surface neo-self-antigen are expressed under the CD11c promoter, we demonstrate that antigen dose dramatically influences T-cell tolerance mechanisms. Moderate antigen expression in both hematopoietic and nonhematopoietic cells favors the development of antigen-specific Treg cells and the establishment of a tolerogenic environment.